Intended for healthcare professionals

CCBYNC Open access

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

BMJ 2018; 363 doi: (Published 05 December 2018) Cite this as: BMJ 2018;363:k4880

Linked editorial

Incretins and cancer of the bile duct in type 2 diabetes